Table 1

Gender-specific UK cancer research funding by cancer site, disease theme, phase of research and development pipeline and by funding organisation

Male PIsFemale PIsFold difference
Award numberSum investment, £Mean award (SD); £Median award (IQR); £Award numberSum investment, £Mean award (SD); £Median award (IQR); £Sum investmentMean awardMedian award
All28901 821 637 149630 324
(1 662 559)
252 647
(127 343–553 560)
1296511 570 050394 730
(666 574)
198 485
(99 317–382 650)
3.61.61.3***
Cancer site
 Head and neck1617 490 7691 093 173
(1 046 928)
637 418
(260 926–2 242 703)
4759 863189 965
(148 630)
183 250
(61 937–317 994)
23.05.83.5
 Cervical1512 678 187845 212
(1 070 241)
353 754
(94 896–1 574 367)
101 281 813128 181
(96 538)
123 623
(30 732–206 392)
9.96.62.9**
 Prostate71125 769 5481 771 402
(6 980 741)
377 700
(190 072–893 840)
189 090 234505 013
(740 863)
188 950
(103 103–360 595)
13.83.52.0
 Colorectal9357 301 015616 139
(750 261)
287 749
(112 437–893 840)
4618 296 468397 749
(522 529)
176 320
(73 736–404 692)
3.11.61.6
 Breast32582 761 091254 649
(420 671)
166 321
(53 832–212 298)
23552 971 924225 412
(414 352)
122 721
(22 583–220 325)
1.61.11.4
 Upper gastrointestinal and oesophageal2312 946 692562 900
(650 867)
274 268
(103 500–9 18 058)
138 736 139672 011
(1 659 329)
190 546
(75 424–240 704)
1.50.81.4
 Lung4217 589 619418 800
(740 402)
159 766
(88 544–284 718)
355 712 151163 204
(192 192)
127 698
(57 173–174 667)
3.12.61.3
 Ovarian2136 259 8181 812 991
(5 165 397)
266 344
(147 327–1 214 534)
257 974 217318 968
(372 325)
224 595
(119 951–276 184)
4.55.71.2
 Brain93 223 573358 174
(170479)
406 122
(215 197–503 831)
126 667 742555 645
(651 240)
346 106
(162 573–702 297)
0.50.61.2
 Haematological791263 742 072333 428
(446 336)
191 200
(122 138–279 643)
360112 494 439312 484
(530 741)
180 981
(112 896–250 059)
2.31.11.1
 Skin4414 797 603336 309
(562 447)
89 456
(70 635–345 581)
427 305 773173 947
(292 287)
85 375
(68 113–215 519)
2.01.91.0
 Renal117 727 390702 490
(675 521)
296 803
(90 509–1 270 928)
86 158 106769 763
(727 809)
542 768
(347 399–822 950)
1.30.90.6
 Mesothelioma172 267 977133 410
(117 199)
104 084
(65 607–174 656)
102 013 884201 388
(49 059)
202 921
(165 605–248 573)
1.10.70.5**
 Liver2411 279 988469 999
(516 869)
250 892
(138 579–687 402)
1213 515 3061 126 276
(1 207 998)
598 732
(240 881–1 679 106)
0.80.40.4*
 Pancreatic94 566 168507 352
(568 171)
260 473
(150 980–650 203)
53 685 298737 059
(461 259)
1 033 948
(236 145–1 033 948)
1.20.70.3
Disease theme
 Psychosocial4311 524 430268 010
(422 656)
164 422
(43 523–274 442)
669 057 598137 236
(251 616)
59 994
(20 803–209 699)
1.32.02.7**
 Men’s health84133 173 6411 585 400
(6 430 067)
364 401
(186 031–855 034)
229 429 269428 603
(687 483)
174 513
(87 844–318 514)
14.13.72.1*
 Surgery5433 398 798618 496
(722 494)
272 279
(109 099–977 969)
143 723 997265 999
(538 442)
131 481
(20 000–243 687)
9.02.32.1*
 Diagnostic, screening and monitoring454277 375 628610 959
(1 353 526)
248 793
(109 256–638 341)
20171 024 311353 354
(509 792)
155 330
(75 224–294 584)
3.91.71.6***
 Radiotherapy8982 782 734930 143
(2 689 204)
283 654
(130 224–445 594)
195 123 806269 674
(265 442)
202 125
(68 219–357 426)
16.23.51.4
 Drug therapy736488 185 281663 295
(2 265 942)
221 228
(116 730–553 560)
336111 111 295330 688
(510 148)
175 374
(79 949–253 435)
4.42.01.3***
 Women’s health361129 487 265358 690
(1 320 959)
168 523
(64 649–222 843)
26567 078 971253 128
(487 672)
131 248
(22 790–230 625)
1.91.41.3
 Immunology (inc biologics)304141 667 662466 012
(885 702)
244 741
(130 741–483 283)
14350 385 497352 346
(383 905)
206 604
(117 699–437 074)
2.81.31.2
 Pathogenesis1714999 693 849583 252
(1 032 142)
269 893
(141 355–538 430)
775355 962 017459 305
(765 925)
225 586
(123 782–448 560)
2.81.31.2***
 Paediatrics11537 509 650326 170
(465 935)
179 839
(81 614–310 647)
5723 804 132417 616
(693 945)
182 305
(113 785–318 681)
1.60.81.0
 Infection-associated8736 098 390414 924
(821 771)
221 742
(131 430–436 959)
4018 326 629458 165
(706 563)
244 555
(140 757–481 060)
2.00.90.9
 Global health75 003 769714 824
(1 421 938)
105 132
(58 229–540 990)
51 431 191286 238
(308 533)
154 344
(98 699–377 559)
3.52.50.7
 Geriatrics3921 777307 259
(409 655)
100 259
(42 410–779 108)
4694 617173 654
(88 857)
178 014
(99 022–248 286)
1.31.80.6
 Occupational health141 993 492142 392
(128 096)
123 659
(25 355–198 248)
3549 492183 164
(34 345)
199 998
(143 649–205 845)
3.60.80.6
Phase of research and development
 Phase I–III182175 953 897966 779
(4 287 134)
217 248
(101 493–700 972)
10938 598 339354 113
(608 791)
117 699
(66 500–236 145)
4.62.71.9***
 Product development10686 729 963818 207
(2 787 935)
230 722
(109 099–515 754)
5414 765 649273 437
(407 013)
150 469
(39 528–251 035)
5.93.01.5**
 Public health304162 533 528534 649
(882 173)
236 768
(91 284–484 162)
18168 169 795376 628
(886 999)
160 196
(59 973–273 731)
2.41.41.5***
 Cross-disciplinary285237 828 497834 486
(1 879 331)
274 442
(136 009–806 082)
14674 822 967512 486
(791 038)
223 617
(105 842–448 477)
3.21.61.2**
 Preclinical19961 154 505 166578 409
(1 131 681)
256 606
(140 073–528 959)
802315 115 408392 912
(602 354)
214 876
(121 572–435 243)
3.71.51.2***
Funding organisation
 Department of Health337326 868 815969 937
(3 477 639)
273 251
(109 256–858 065)
20971 189 261340 618
(513 879)
175 000
(75 424–281 131)
4.62.81.6***
 MRC505640 884 7521 269 079
(2 052 363)
592 592
(351 917–1 348 289)
253188 994 003747 011
(943 859)
434 495
(254 487–748 000)
3.41.71.4***
 Wellcome121116 858 787965 775
(2 035 860)
250 809
(165 274–689 373)
7023 266 670332 381
(609 652)
194 697
(154 344–266 487)
5.02.91.3*
 Charity (excluding Wellcome and CRUK)1101281 584 160255 753
(372 649)
163 214
(90 000–230 289)
585130 457 245223 003
(427 557)
137 865
(67 135–206 068)
2.21.11.2***
 EPSRC292163 856 870561 153
(939 912)
319 486
(147 583–605 290)
6337 693 709598 312
(1 126 384)
258 057
(114 605–600 998)
4.30.91.2
 BBSRC416186 189 724447 571
(410 166)
373 556
(268 819–509 467)
8835 754 106406 296
(277 730)
385 328
(290 714–480 990)
5.21.11.0
 European Commission (inc ERC)3656 188 9661 560 805
(426 113)
1 414 393
(1 261 751–1 768 211)
914 693 3231 632 591
(395 550)
1 383 393
(1 361 130–2 063 706)
3.81.01.0
 Other8249 205 075600 061
(2 096 627)
144 907
(92 673–268 658)
199 521 733501 143
(773 838)
50 403
(25 092–1 013 231)
5.21.22.9
  • Cancer sites with fewer than 15 total awards are not presented in this table.

  • We were unable to identify the phase of research and development for 26 studies.

  • *P<0.05, **P<0.01, ***P<0.001.

  • BBSRC, Biotechnology and Biological Sciences Research Council; CRUK, Cancer Research UK; EPSRC, Engineering and Physical Science Research Council; ERC, European Research Council; MRC, Medical Research Council; PI, primary investigator.